The largest database of trusted experimental protocols

Brdu labeling and detection kit

Manufactured by Roche
Sourced in United States, Germany

The BrdU labeling and detection kit is a laboratory tool used for the detection and visualization of cells that have incorporated the synthetic thymidine analog bromodeoxyuridine (BrdU) during DNA synthesis. The kit provides the necessary reagents and protocols to label, detect, and quantify BrdU-positive cells, which is a common technique in cell proliferation and cell cycle studies.

Automatically generated - may contain errors

40 protocols using brdu labeling and detection kit

1

Prostate Cancer Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
MIGR-hKCTD11-infected prostate cancer cell lines were cultured onto a 12 mm diameter glass. After 24 hrs, BrdU was added (BrdU labeling and detection kit, Boehringer Mannheim) according to the manufacturer's instructions. Cells were incubated for 8 and for 24 hours and then fixed in 4% paraformaldehyde for 10 min, permeabilized with 0.25% Triton X in PBS, washed, and incubated with primary antibody (anti-GFP, Santa Cruz Biotechnology). After 1 hr, cells were washed and incubated with goat anti-rabbit Alexa Flour 488 (Santa Cruz Biotech) secondary antibody for 45 min. Cells were treated with 4% paraformaldehyde and then 2 N HCl. After three washes, cells were incubated with 1 : 10 primary anti-BrdU (BrdU labeling and detection kit, Boehringer Mannheim) and, afterward, with goat anti-mouse IgG TRITC (Sigma-Aldrich) secondary antibody. Hoechst was used for nuclear staining. Cells were analyzed by using a Zeiss Axioplan 2 (Carl Zeiss) fluorescence microscope.
+ Open protocol
+ Expand
2

BrdU Labeling and Immunofluorescence Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used a bromodeoxyuridine (BrdU) labeling and detection kit from Boehringer Mannheim (Germany). Cells were seeded on glass slides, incubated for 1 h with BrdUrd (final concentration of 10 µmol/L), fixed, and permeabilized with ethanol-glycine solution. Slides were incubated with anti-BrdU mouse monoclonal antibody and with a fluorescein (FITC)-conjugated secondary antibody (Boehringer Mannheim, Mannheim, Germany) and mounted in PBS 1X-Glycerol on specimen holder slide.
For immunofluorescence, MDM2 was revealed with an anti-MDM2 primary antibody and fluorescein (FITC)-conjugated secondary antibodies (Jackson Immuno Research Laboratories, Inc., Philadelphia, PA, USA). Cell nuclei were identified by Hoechst 33258 (final concentration of 1 µg/mL; Sigma ChemicalCo.) staining. The fluorescent signal was visualized with an epifluorescent microscope (Axiovert 2, Zeiss; equipped with a ×100 lens) interfaced with the image analyzer software KS300 (Zeiss). At least 100 GFP-positive cells were counted in five different microscopic fields.
+ Open protocol
+ Expand
3

C2C12 Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
C2C12 MBs (1×104 cells/well, 100μl) were seeded into 96-well plates for 24 hours. Fresh serum free medium containing the indicated concentrations of CCL2 was added. Cell proliferation was measured by monitoring BrdU incorporation. Cells were incubated with BrdU for 3 hours, and then cell proliferation was assayed using a BrdU labeling and detection kit (Roche, Mannheim, Germany). Absorbance was measured at 450 nm, with a reference wavelength of 650 nm, using a microplate reader (BioTek Epoch Gen5).
+ Open protocol
+ Expand
4

PTEN Regulation of MRC-5 Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
MRC-5 cells were seeded on glass slides in 24-well plates and transfected with PTEN siRNA or NC siRNA for 24 h without FBS, followed by incubation with MEM-α containing 10 % FBS and antibodies for another 24 h. BrdU incorporation was measured using a BrdU labeling and detection kit (Roche, Mannheim, Germany) in accordance with the manufacturer’s protocol. Briefly, MRC-5 cells were labeled with 10 μM BrdU during an incubation of 50 min. After labeling, the cells were washed three times, fixed, and treated with mouse anti-BrdU monoclonal antibody for 30 min at 37 °C, followed by an anti-mouse-Ig-fluorescein working solution. Cells were washed three times and mounted with DAPI-containing mounting media (ZSGB-BIO, Beijing, China). Cellular proliferation was assessed by the percent of BrdU-staining cells in nuclear-positive cells in the same microscopic visual field. Experiments were performed three independent times. The BrdU positive rate was evaluated by counting five different microscopic fields per time point.
+ Open protocol
+ Expand
5

Quantifying Bovine Hyalocyte Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to determine the extent of cellular proliferation of bovine hyalocytes, the incorporation of BrdU was quantified using a BrdU labeling and detection kit (11296736001; Roche, Indianapolis, IN), following the manufacturer's instructions. Briefly, 1 × 10 4 cells were cultured in DMEM (Nacalai Tesque) in 96-well mL plates at 37 C under 5% CO 2 . Cells were washed 24 h after plating, and the media were replaced with 100 mL vitreous from ERM or PDR patients. At 48 h after stimulation, 10 mmol/L BrdU was added to each well. The cells were continuously cultured under the same conditions for 2 h, during which BrdU was incorporated into freshly synthesized DNA. Following fixation of cells, cellular DNA was partially digested by nuclease treatment. The incorporated BrdU was detected and quantified using a peroxidase-labeled antibody for BrdU. Peroxidase catalyzes the cleavage of the substrate, which produces a color reaction. The absorbance at 450 nm was directly correlated to the level of BrdU incorporated into cellular DNA and was measured using a microplate reader (Bio-Rad) to assess the extent of hyalocyte proliferation.
+ Open protocol
+ Expand
6

BrdU Labeling for Kidney Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
BrdU was administered to the mice (i.p., 1.5 mg/day) for 3 or 7 days before kidney collection. BrdU immunofluorescent staining was performed according to the manufacturer’s instructions (BrdU Labeling and Detection Kit, Roche, Indianapolis, IN, USA).
+ Open protocol
+ Expand
7

Quantifying Cell Proliferation in Mouse Embryos

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation activity was evaluated by 5-bromodeoxyuridine (BrdU) labeling and immunofluorescence staining (37 (link)). Briefly, timed pregnant mice were injected intraperitoneally with BrdU solution (3 mg/100 g of body weight) from a BrdU labeling and detection kit (Roche) 30 min before embryo harvesting. The collected embryos were fixed in 4% paraformaldehyde solution at 4 °C for 1 h and embedded in paraffin. Then embryos were processed for paraffin sectioning at 5 μm for immunohistochemical staining. BrdU-labeled cells were detected immunohistochemically in paraffin sections according to the manufacturer’s instructions. Apoptosis was assayed by TUNEL staining using the In Situ Cell Death Detection Kit (Roche) according to the manufacturer’s protocol. The cell proliferation rate was counted (n = 3–6 samples) and calculated as the percentage of BrdU-labeled cells among total nuclear stained cells (4′,6-diamidino-2-phenylindole [DAPI] positive) within a defined arbitrary area. The proliferation rate of control (ShhCre) embryos was set to 1, and then the relative proliferation rate of Isl1ShhCre mutant embryos was calculated.
+ Open protocol
+ Expand
8

Platelet-Mediated Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fifty thousand cells IG10 or ID8 were plated in 6-well plates and grown in serum-free media (SFM) for 24 h. Mouse platelets (20 × 106 per well) isolated as described above were added to the cells. After 48 h of incubation, cell proliferation was analyzed using the BrdU labeling and Detection Kit (Roche, Indianapolis, USA) according to the manufacturer’s instructions. Briefly, cells were pulse-labeled with 10 μM BrdU for 90 min, washed three times with PBS, detached with 0.25% Trypsin-EDTA, fixed with 70% ethanol fixative for 20 min, immunostained with mouse anti-BrdU primary antibody and anti-mouse Ig-fluorescein secondary antibody, and finally analyzed using flow cytometry (EPICS XL 4-Color Cytometer; Beckman Coulter, Brea, USA). The assay was performed for 3 times.
+ Open protocol
+ Expand
9

BrdU and Ki67 Imaging of Panc-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BrdU labeling and detection kit (Roche) was used to detect the BrdU incorporation into cellular DNA as per the manufacturer’s instructions. Cells were fixed and visualized with a research fluorescence microscope (AX10 Observer SD; Carl Zeiss) at 200× magnification at room temperature. Ki67 protein was detected by immunostaining of Panc-1 cells using a rabbit antibody directed against Ki67 (1:50 dilution; Abcam) and secondary goat anti–rabbit conjugated Alexa Fluor 488 (1:200 dilution; Molecular Probe). Hoechst 33258 nuclear dye was used to visualize the nucleus. Cells were fixed and imaged with a research fluorescence microscope (AX10 Observer SD) under the magnification of 630× at room temperature. Image acquisition was performed using ZEN software (Carl Zeiss).
+ Open protocol
+ Expand
10

Cardiomyocyte Differentiation and Cell Cycle Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
4 weeks after initiation of cardiomyocyte differentiation, 5-Bromo-2′-deoxy-uridine (Brdu, 15 μM final concentration) was added to the culture medium for 12 hours; then, the cells were fixed with ethanol at –20°C for 15 minutes, and Brdu staining was performed with a Brdu Labeling and Detection Kit (Roche life science, Inc. Cat # 11296736001) as directed by the manufacturer’s instructions. The expression of other cell cycle markers (Ki67, phosphorylated histone H3 [PH3], and Aurora-B) was evaluated with the corresponding antibodies (Supplemental Table II) in ethanol-fixed cells that had been counter-stained for the expression of hcTnT and human Nkx2.5 to confirm hiPSC-CM identity. The number of nuclei that stained positively for each marker were counted, normalized to the total number of hiPSC-CMs (i.e., the number of hcTnT/Nkx2.5 double-positive cells), and expressed as a percentage.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!